Clin Drug Invest. 2006;26(10):547-557.

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

Bethesda, MD) for the treatment of chronic, idiopathic constipation in adults. In 2008, the FDA approved lubiprostone (Amitiza ®) for the treatment of constipation-predominant IBS in women ≥18 ...

Background: Chronic idiopathic urticaria is a distressing condition that severely affects patients' quality of life. The overall costs associated with this disease, both for the healthcare payer ...

Constipation can make you feel constantly bloated or uncomfortable. You may also experience harmful side effects, such as bowel obstructions, due to chronic constipation. An estimated 15% of ...

The company’s flagship drug, Linzess (linaclotide) is indicated for the treatment of irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC). Ironwood has a ...

The irritable bowel syndrome, functional abdominal bloating, functional constipation, and functional diarrhea are distinguished by symptom-based diagnostic criteria. Unspecified FBD lacks criteria for ...

After hours: December 20 at 7:57:26 PM EST Loading Chart for IRWD ...

After hours: December 24 at 4:59:23 p.m. EST ...

After hours: 20 December at 19:58:32 GMT-5 ...

Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...